{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:49:49Z","timestamp":1790909389470,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI094586"],"award-info":[{"award-number":["R01 AI094586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J. Intern. AIDS Soc."],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Young women in Southern Africa have extremely high HIV incidence rates necessitating the availability of female\u2010controlled prevention methods. Understanding adolescent preference for seeking contraception would improve our understanding of acceptability, feasibility and adherence to similar modes of delivery for HIV prevention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>UChoose was an open\u2010label randomized crossover study over 32\u00a0weeks which aimed to evaluate the acceptability and preference for contraceptive options in healthy, HIV\u2010uninfected, female adolescents aged 15 to 19\u00a0years, as a proxy for similar HIV prevention methods. Participants were assigned to a contraceptive method for a period of 16\u00a0weeks in the form of a bi\u2010monthly injectable contraceptive, monthly vaginal Nuvaring<jats:sup>\u00ae<\/jats:sup> or daily combined oral contraceptive (COC) and then asked to state their preference. At 16\u00a0weeks, participants crossed over to another contraceptive method, to ensure that all participants tried the Nuvaring<jats:sup>\u00ae<\/jats:sup> (least familiar modality) and additionally, either the injection or COC. Primary outcomes were contraceptive acceptability and preference. At the end of the 32\u00a0weeks they were also asked to imagine their preference for an HIV prevention modality. Secondary endpoints included changes in sexual behaviour, contraceptive adherence and preference for biomedical and behavioural HIV prevention methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 180 participants screened, 130 were enrolled and randomized to the Nuvaring<jats:sup>\u00ae<\/jats:sup> (n\u00a0=\u00a045), injection (n\u00a0=\u00a045) or COC (n\u00a0=\u00a040). Significantly more Nuvaring<jats:sup>\u00ae<\/jats:sup> users (24\/116; 20.7%) requested to change to another contraceptive option compared to injection (1\/73; 1.4% <jats:italic>p<\/jats:italic>\u00a0=\u00a00.0002) and COC users (4\/49; 8% <jats:italic>p<\/jats:italic>\u00a0=\u00a00.074). Of those that remained on the Nuvaring<jats:sup>\u00ae<\/jats:sup>, adherence was significantly higher than to COC (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.0001). Significantly more injection users (77\/80; 96.3%) thought this delivery mode was convenient to use compared to Nuvaring<jats:sup>\u00ae<\/jats:sup> (74\/89; 83.1%; <jats:italic>p<\/jats:italic>\u00a0=\u00a00.0409) or COC (38\/50; 76.0%; <jats:italic>p<\/jats:italic>\u00a0=\u00a00.0034). Overall, the preferred contraceptive choice was injection, followed by the ring and lastly the pill.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Adherence to daily COC was difficult for adolescents in this cohort and the least favoured potential HIV prevention option. While some preferred vaginal ring use, these data suggest that long\u2010acting injectables would be the preferred prevention method for adolescent girls and young women. This study highlights the need for additional options for HIV prevention in youth.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jia2.25626","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T12:40:24Z","timestamp":1602247224000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["An open\u2010label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose)"],"prefix":"10.1002","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3372-9506","authenticated-orcid":false,"given":"Katherine","family":"Gill","sequence":"first","affiliation":[{"name":"Desmond Tutu HIV Centre University of Cape Town Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna\u2010Ursula","family":"Happel","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine Faculty of Health Sciences University of Cape Town Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Pidwell","sequence":"additional","affiliation":[{"name":"Desmond Tutu HIV Centre University of Cape Town Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mendelsohn","sequence":"additional","affiliation":[{"name":"Desmond Tutu HIV Centre University of Cape Town Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menna","family":"Duyver","sequence":"additional","affiliation":[{"name":"Desmond Tutu HIV Centre University of Cape Town Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Johnson","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases Epidemiology and Research School of Public Health and Family Medicine University of Cape Town Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon","family":"Meyer","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases Epidemiology and Research School of Public Health and Family Medicine University of Cape Town Cape Town South Africa"},{"name":"Division of Epidemiology and Biostatistics School of Public Health and Family Medicine University of Cape Town Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6608-0248","authenticated-orcid":false,"given":"Catherine","family":"Slack","sequence":"additional","affiliation":[{"name":"HIV AIDS Vaccines Ethics Group University of KwaZulu\u2010Natal Durban South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Strode","sequence":"additional","affiliation":[{"name":"HIV AIDS Vaccines Ethics Group University of KwaZulu\u2010Natal Durban South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Mendel","sequence":"additional","affiliation":[{"name":"Desmond Tutu HIV Centre University of Cape Town Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Fynn","sequence":"additional","affiliation":[{"name":"Desmond Tutu HIV Centre University of Cape Town Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Wallace","sequence":"additional","affiliation":[{"name":"Cancer Association of South Africa Johannesburg South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Spiegel","sequence":"additional","affiliation":[{"name":"Department of Health and Human Services Kelly Government Solutions Contractor to National Institute of Allergy and Infectious Diseases National Institutes of Health Rockville MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Jaspan","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine Faculty of Health Sciences University of Cape Town Cape Town South Africa"},{"name":"Departments of Pediatrics and Global Health University of Washington Seattle WA USA"},{"name":"Centre for Global Infectious Disease Research Seattle Children\u2019s Research Institute Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u2010Ann","family":"Passmore","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine Faculty of Health Sciences University of Cape Town Cape Town South Africa"},{"name":"National Health Laboratory Service (NHLS) Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybil","family":"Hosek","sequence":"additional","affiliation":[{"name":"Stroger Hospital of Cook County Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionne","family":"Smit","sequence":"additional","affiliation":[{"name":"MSD (Pty) Ltd Halfway House South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Rinehart","sequence":"additional","affiliation":[{"name":"ViiV Healthcare Research Triangle Park NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-4386","authenticated-orcid":false,"given":"Linda\u2010Gail","family":"Bekker","sequence":"additional","affiliation":[{"name":"Desmond Tutu HIV Centre University of Cape Town Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"UNAIDS.UNAIDS DATA 2018[Internet].2018[cited 2020 Mar 31]. Available from:https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/unaids\u2010data\u20102018_en.pdf"},{"issue":"15","key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eclinm.2019.08.007","article-title":"Targeting the HIV epidemic in South Africa: the need for testing and linkage to care in emergency departments","volume":"1","author":"Hansoti B","year":"2019","journal-title":"EClinicalMedicine"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212445"},{"key":"e_1_2_8_5_1","unstructured":"SANAC.The South African National Strategic Plan for HIV TB and STIs. [Internet]. [cited 2020 Mar 31]. Available from:https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/unaids\u2010data\u20102018_en.pdf"},{"key":"e_1_2_8_6_1","unstructured":"UNAIDS.UNAIDS data 2019[Internet].2019[cited 2020 Mar 31]. Available from:https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2019\u2010UNAIDS\u2010data_en.pdf"},{"issue":"1","key":"e_1_2_8_7_1","first-page":"1","article-title":"What explains gender inequalities in HIV\/AIDS prevalence in sub\u2010Saharan Africa? Evidence from the demographic and health surveys","volume":"16","author":"Sia D","year":"2016","journal-title":"BMC Public Health"},{"key":"e_1_2_8_8_1","unstructured":"UNICEF.UNICEF: Working To End Aids For Every Child. Advocacy Brochure[Internet].2018[cited 2020 Mar 31]. Available from:https:\/\/www.unicef.org\/sites\/default\/files\/2018\u201007\/UNICEF\u2010Advocacy\u2010Brochure.pdf"},{"key":"e_1_2_8_9_1","unstructured":"UNAIDS.UNAIDS HIV prevention among adolescent girls and young women[Internet].2016[cited 2020 Mar 31]. Available from:https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_HIV_prevention_among_adolescent_girls_and_young_women.pdf"},{"key":"e_1_2_8_10_1","unstructured":"WHO.WHO | HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV[Internet] [cited 2020 Mar 31]. Available from:https:\/\/www.who.int\/hiv\/pub\/guidelines\/adolescents\/en\/"},{"issue":"1","key":"e_1_2_8_11_1","article-title":"Predicting condom negotiation efficacy in economically disadvantaged adolescents","volume":"1","author":"Okonkwo C","year":"2019","journal-title":"J Prof Couns Psychother Res"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.7196\/SAMJ.2015.v105i11.10222"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25282"},{"key":"e_1_2_8_14_1","doi-asserted-by":"crossref","unstructured":"FernandezC vanHalsemaCL.Evaluating cabotegravir\/rilpivirine long\u2010acting injectable in the treatment of HIV infection: Emerging data and therapeutic potential. Vol. 11 HIV\/AIDS \u2010 Research and Palliative Care. Dove Medical Press Ltd.;2019;179\u201392.","DOI":"10.2147\/HIV.S184642"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002690"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02808-2"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25408"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01143-8"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028238"},{"key":"e_1_2_8_20_1","unstructured":"Developing Adolescents A Reference for Professionals[Internet].Washington DC:American Psychological Association;2002[cited 2020 Mar 31]. Available from:https:\/\/www.apa.org\/pi\/families\/resources\/develop.pdf"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.03.033"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25528"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001945"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-019-02418-7"},{"key":"e_1_2_8_25_1","doi-asserted-by":"crossref","unstructured":"BekkerL RebeK VenterF MaartensG MoorhouseM ConradieF et al.Southern African guidelines on the safe use of pre\u2010exposure prophylaxis in persons at risk of acquiring HIV\u20101 infection[Internet]. Vol. 17 South African Journal of HIV Medicine. Medpharm Publications;2016[cited 2020 Apr 1].1\u201311. Available from:http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29568613","DOI":"10.4102\/sajhivmed.v17i1.455"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001567"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000362"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001511"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002244"},{"key":"e_1_2_8_30_1","doi-asserted-by":"crossref","first-page":"e25094","DOI":"10.1002\/jia2.25094","article-title":"The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention","volume":"21","author":"Van der Straten A","year":"2018","journal-title":"J Int AIDS Soc"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25626","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jia2.25626","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T23:56:24Z","timestamp":1693871784000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.25626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1002\/jia2.25626"],"URL":"https:\/\/doi.org\/10.1002\/jia2.25626","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"2020-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e25626"}}